key: cord-0768793-bcx5if21
authors: Yock-Corrales, Adriana; Lenzi, Jacopo; Ulloa-Gutiérrez, Rolando; Gómez-Vargas, Jessica; Antúnez-Montes, Omar Yassef; Rios Aida, Jorge Alberto; del Aguila, Olguita; Arteaga-Menchaca, Erick; Campos, Francisco; Uribe, Fadia; Díaz, Roger Hernández; Buitrago, Andrea Parra; Londoño, Lina Maria Betancur; Kozicki, Verónica; Brizuela, Martin; Buonsenso, Danilo
title: Acute Abdomen and Appendicitis in 1010 Pediatric Patients With COVID-19 or MIS-C: A Multinational Experience from Latin America
date: 2021-07-13
journal: Pediatr Infect Dis J
DOI: 10.1097/inf.0000000000003240
sha: 027dc6a7e9e7a3c53e00f123f314e80aa63f43b9
doc_id: 768793
cord_uid: bcx5if21

To date, there are only sporadic reports of acute abdomen and appendicitis in children with coronavirus disease 2019 (COVID-19) and multisystem inflammatory syndrome in children (MIS-C). METHODS: Children 17 years of age or younger assessed in 5 Latin American countries with a diagnosis of microbiologically confirmed severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection and children fulfilling MIS-C definition were included. For children with acute abdomen, we investigate main radiologic patterns, surgical treatment and intraoperative findings, outcomes. FINDINGS: One-thousand ten children were enrolled. Forty-two children (4.2%) had a clinical diagnosis of acute abdomen. Four (9.5%) were diagnosed with MIS-C and did not undergo surgery. The remaining 38 children (3.8%) underwent abdominal surgery due to suspected appendicitis, 34 of them (89.7%) had an intraoperative diagnosis of acute appendicitis (AA), while 4 of them had nonsurgical findings. Eight children died (0.8%), none of them being diagnosed with appendicitis. Children with AA were significantly older than those without (P < 0.0001). Children with complicated appendicitis had more frequently fever (85.7% vs. 60%), intestinal distension on the abdominal radiograph (7.1% vs. none), leukocytosis (85.7% vs. 40%) and high levels of C-reactive protein (35.7% vs. 5%), although differences were not statistically significant. CONCLUSIONS: Our study showed that children may present with acute abdomen during COVID-19 or MIS-C, which is not always associated with intraoperative findings of appendicitis, particularly in case of MIS-C. Further studies are needed to better characterize children with acute abdomen during COVID-19 or MIS-C, to avoid delay in diagnosis of surgical conditions and at the same time, minimize unnecessary surgical approaches.

C linical features of coronavirus disease 2019 in children have resulted in a mild disease in the majority of patients. 1 Abdominal pain is one of the most common reasons for child's assessment in the pediatric emergency departments with over 1,345,000 annual visits in the US in under 15 years of age. 2 Acute appendicitis (AA) is the most common abdominal surgical emergency in childhood with an incidence of 1-2 cases per 100,000 children per year between birth and 4 years to 25 cases for every 10,000 children between 10 and 17 years. 3 Incidence of AA in children with COVID-19 is unknown, with sporadic publications of small case series. 4 Also, surgical outcomes in this pediatric population with severe acute respiratory syndrome coronavirus 2 (SARS CoV-2) needing an abdominal surgery are not well studied.

Antibiotic therapy for uncomplicated appendicitis is an alternative option that can be safely used in selected patients with an increased risk of recurrent appendicitis in 20% of the cases, without increasing the likelihood of perforation. 5 In the context of COVID-19, nonoperative management of AA is an alternative to surgery with low failure and complication rates. 6 Delayed presentation in patients with AA during the pandemic has been reported, leading to major risk of perforation in younger patients and more complications during hospitalization. 7, 8 Children with COVID-19 may present with clinical features suggestive of appendicitis/AA in relation to terminal ileitis and it has not been clear whether appendicitis might occur as a complication of SARS-CoV-2 infection. 9 Multisystem inflammatory syndrome in children (MIS-C), another entity related to SARS-CoV-2 infection, was also reported as a mimicker of AA. 10, 11 Since cases are constantly raising worldwide, it is expected that SARS-CoV-2 will circulate still for a long time; therefore, the appropriate management of children with COVID-19 is a priority. While the pandemic only determined a limited direct impact on children, delayed diagnosis of patients with AA and COVID-19 could lead to increased morbidity. Due to the gap in the available literature, we performed a multinational study in Latin America aiming to describe the presentation and possible delays of pediatric patients with AA and COVID-19.

This study is part of an ongoing independent, unfunded project that aims to provide urgent information on COVID-19 and MIS-C in Latin American children. The project was presented during the first peak in Latin America 12 and led to the publication of different papers describing an initial group of 409 children with confirmed COVID-19, 1 antibiotic uses in children with COVID-19 or with MIS-C, 13 and the impact of sex on disease severity in children. 14 For the current study, we aimed to assess the diagnoses of AA in children with COVID-19 or with MIS-C. We implemented the previously used dataset 1,12-14 including specific variables for this aim: clinically diagnosed acute abdomen; abdominal ultrasound; abdominal radiograph; complete blood count and C-reactive protein (CRP); surgical findings; culture results from intraoperative specimens. Appendicitis with peritonitis or abdominal abscesses were considered as complicated. These adjunctive data were collected only for children with a clinical diagnosis of appendicitis, since the current emergency situation in Latin America and the burden on health workers, along with the lack of dedicated research resources in our Institutions, did not allow a comprehensive data collection for all children. The remaining variables were collected for all children and are those previously used and included: age, gender, symptoms, imaging, underlying medical conditions, need for hospital and neonatal intensive care unit/pediatric intensive care unit (PICU) admission, respiratory and cardiovascular support, other viral coinfections, drugs used to treat COVID-19, development of MIS-C and type of organ involvement, and outcome. SARS-CoV-2 infection was defined as a positive polymerase chain reaction (PCR) test on nasopharyngeal swab. MIS-C due to SARS-CoV-2 was defined according to the Centers for Disease Control and Prevention criteria. The study was reviewed and approved by the CoviD in sOuth aMerIcaN childrenstudy GrOup core group and approved by the ethics committee of the coordinating center and by each participating center (Mexico: COMINVETICA-30072020-CEI0100120160207; Colombia: PE-CEI-FT-06; Peru: No. 42-IETSI-ESSALUD-2020 and Costa Rica: CEC-HNN-243-2020). The study was conducted in accordance with the Declaration of Helsinki and its amendments. No personal or identifiable data were collected during the conduct of this study.

Summary statistics were presented as counts and percentages. Crude comparisons between groups were evaluated with the chi-squared test or Fisher's exact test, as appropriate. The association of relevant demographic characteristics and clinical factors with the diagnosis of appendicitis was assessed through logistic regression analysis; the effect size of covariates was expressed by odds ratios with 95% confidence intervals (CIs), and the presence of systematic differences (i.e., statistical significance) was assessed using the 2-sided Wald test. Standard errors were adjusted for clustering of patients within hospitals (m = 8). All data were analyzed using Stata version 15 (StataCorp. 2017. Stata Statistical Software: Release 15. College Station, TX: StataCorp LP). The significance level was set at 5%.

A total of 1010 children were enrolled: 941 children (93.2%) with COVID-19 and 69 children (6.8%) with MIS-C: Peru (n = 391, 38.7%), Costa Rica (n = 303, 30%), Argentina (n = 260, 25.7%), Colombia (n = 44, 4.4%) and Mexico (n = 12, 1.2%).

The demographic and clinical characteristics of the 1010 study patients, and according to the final diagnosis of appendicitis or not, are summarized in Table 1 . Four hundred ninety-four (48.9%) were female. A total of 323 (32%) children were admitted to the hospital and 47 (4.7%) required admission to a PICU.

Forty-two children (4.2%) had a clinical diagnosis of acute abdomen. Of them, 4 (9.5%) were diagnosed with MIS-C and did not undergo surgery. The remaining 38 children (3.8% of the study population) underwent abdominal surgery due to suspected appendicitis, 34 of them (89.7%) had an intraoperative diagnosis of AA, while 4 of them had nonsurgical findings (mesenteric adenitis in 2 cases, and normal abdominal findings in the remaining 2). The 2 children with mesenteric adenitis but no appendicitis who underwent surgery, were eventually diagnosed with MIS-C with myocarditis. Eight children died (0.8%), none of them being diagnosed with appendicitis. Further details are described in Table 1 .

Children with AA were significantly older than those without (P < 0.0001) and did not experience a delay at diagnoses, compared with the other group (Table 1) . Table 2 describes details of the cohort of children with appendicitis and according to the presence of surgical complications or not (peritonitis, abdominal abscesses). Children with complicated appendicitis had more frequently fever (85.7% vs. 60%), intestinal distension on the abdominal radiograph (7.1% vs. none), leukocytosis (85.7% vs. 40%) and high levels of CRP (35.7% vs. 5%), although differences were not statistically significant probably due to the overall low number of children with appendicitis. On multivariate analyses (Table 3) , age >5 years was associated with a higher risk of appendicitis (P < 0.001, 95% CI: 4.17-32.83), while the presence of upper respiratory tract symptoms with a reduced risk (P = 0.019, 95% CI: 0.02-0.71).

Abdominal pain is one of the clinical manifestations in children with COVID-19 and the MIS associated with SARS CoV-2 infection. According to available literature, it has been shown that patients with MIS-C could present in up to 30% as an acute abdomen. [15] [16] [17] To our knowledge, this is the first multinational study assessing the outcomes of AA in children with COVID-19 and MIS-C. We found that a non-negligible percentage of children with COVID-19 or MIS-C presented with the acute abdomen (42 children, 4.2%) and 34 had AA. Interestingly, 4 children underwent surgery without finding surgical reasons for the abdominal pain, suggesting that COVID-19 and MIS-C can both present with acute abdomen and simulate appendicitis. In fact, a recent case series clearly showed that MIS-C can have a similar presentation with acute enteritis or acute abdomen for surgical reasons and the conditions may be misdiagnosed. 18 There are reports of case series of pediatric patients with AA during COVID-19 and MIS-C which describe the relationship between this infection and delays in diagnosis and management. 4, 19, 20 In our study, we found a low prevalence of diagnosis of AA (4.2%) but higher than other reported series. 21 Gastrointestinal symptoms were present in a third of all COVID-19 patients and present in all patients with the diagnosis of AA. Similar findings were reported by Tullie et al and Meyer et al. 19, 22 The delay in the approach and treatment of patients with AA implies a higher risk of perforation and complications leading to an increased length of stay. 8 However, we did not find that a delay in the diagnosis of appendicitis in these patients was associated with a higher incidence of complications (41.1%). Complications rate in Israel were reported in 22% associated with parental concern in contracting COVID-19 in the hospital, inadequate clinical evaluation and settings for clinical evaluation (telemedicine), and the lack of healthcare worker's instructions in regard to the time to seek medical advice 8 About the management of AA, 81% of our patients underwent surgery as the preferred modality of treatment; this differs from the practice reported in some hospitals that suggest conservative management of patients with the diagnosis of SARS-CoV-2 and acute abdomen. 6, 7 Some centers have used more conservative approaches for uncomplicated cases of AA in patients with 

COVID-19 and multisystem inflammatory syndrome in Latin American children: a multinational study

National Hospital Ambulatory Medical Care Survey: 2017 emergency department summary tables

The epidemiology of appendicitis and appendectomy in the United States

Acute appendicitis in multisystem inflammatory syndrome in children with COVID-19

Antibiotic treatment and appendectomy for uncomplicated acute appendicitis in adults and children: a systematic review and meta-analysis

Rate of application and outcome of non-operative management of acute appendicitis in the setting of COVID-19: systematic review and meta-analysis

Delayed presentation and suboptimal outcomes of pediatric patients with acute appendicitis during the COVID-19 pandemic

Delayed diagnosis of paediatric appendicitis during the COVID-19 pandemic

Role of angiotensin-converting enzyme 2 (ACE2) in COVID-19

Multisystem inflammatory syndrome in SARS-CoV-2 infection mimicking acute appendicitis in children

A case of multisystem inflammatory syndrome in children mimicking acute appendicitis in a COVID-19 pandemic area

COVID-19 in South American children: a call for action

High rates of antibiotic prescriptions in children with COVID-19 or multisystem inflammatory syndrome: a multinational experience in 990 cases from Latin America

Influence of sex on disease severity in children with COVID-19 and multisystem inflammatory Syndrome in Latin America

Clinical characteristics of 10 children with a pediatric inflammatory multisystem syndrome associated with COVID-19 in Iran

Intestinal ischemia secondary to COVID-19

Kawasaki-like multisystem inflammatory syndrome in children during the COVID-19 pandemic in Paris, France: prospective observational study

Acute appendicitis in four children with SARS-CoV-2 infection

Multisystem inflammatory syndrome in children. An emerging clinical challenge for pediatric surgeons in the COVID 19 era

Acute appendicitis in children during the COVID-19 pandemic: neither delayed diagnosis nor worse outcomes

Gastrointestinal features in children with COVID-19: an observation of varied presentation in eight children

Cape Town MISC-Team. Multisystem inflammatory syndrome in children in South Africa

Mistaken MIS-C: a case series of bacterial enteritis mimicking MIS-C

Non-operative management of acute appendicitis in a pediatric patient with concomitant COVID-19 infection

COVID-19, including home care and nonoperative management with antibiotics. 23 Reports of patients with AA and MIS-C has been described as part of the clinical features of the inflammatory syndrome. 4, 22, 24 In our study, we found 4 patients with MIS-C and a clinical diagnosis of the acute abdomen who were treated with nonoperative management with no overall complications, suggesting that appendicitis was not the cause of abdominal pain. Interestingly, we also found 4 children who underwent but had not intra-operative findings of appendicitis, suggesting that the inflammatory response was the cause of pain rather than appendicitis. Two of these patients had mesenteric adenitis and were eventually diagnosed with MIS-C, supporting the evidence that AA may be one of the presenting symptoms of MIS-C and the difficulty in distinguishing the 2 conditions. Our study has some limitations to address. We could not determine the time from diagnosis and the surgical management, limiting the result of the association between delayed treatment and complications. The small number of patients with AA and COVID-19 could be less than the real number of patients with these 2 conditions because a large proportion of children have not been tested with PCR test on nasopharyngeal test due to unavailability of them during certain periods of the pandemic, as may have happened in low-to-middle income countries settings worldwide. Despite these limitations, this study provides the largest overview of AA in children with COVID-19 and MIS-C to date.In conclusion, our study found that both MIS-C and COVID-19 can present acute abdomen, with or without appendicitis. Further studies are needed to better recognize these cohorts of children and optimize diagnosis and both conservative or surgical treatment.